# ðŸš€ eyentelligence: Startup Business Plan (Year 0-1)

**Company**: eyentelligence  
**Founded**: 2024  
**Mission**: Understanding communication from cells to minds  
**Vision**: Transform healthcare through mechanistic AI and precision medicine

---

## Executive Summary

eyentelligence operates **two complementary platforms** addressing different markets with shared technology infrastructure:

### **Platform 1: cognisom** (B2B/Research)
GPU-accelerated cellular simulation platform for cancer research, drug development, and precision medicine.

### **Platform 2: eyentell** (B2B SaaS)
Privacy-first, AI-powered client management platform for legal, counseling, and mental health professionals.

### **Shared Infrastructure**
- NVIDIA GPU acceleration
- Vector database (pgvector) for memory/knowledge
- Microservices architecture
- Privacy-first design (HIPAA-compliant)
- AI/ML capabilities

### **Startup Phase Focus** (Months 0-12)
**Primary**: Secure non-dilutive funding (grants, credits) for cognisom development  
**Secondary**: Build eyentell MVP for early revenue generation  
**Goal**: Achieve technical validation + $10-50K MRR by Month 12

---

## 1. Business Model Overview

### Platform 1: cognisom (Cancer Research)

#### **Target Market**
- **Primary**: Academic cancer researchers (universities, research institutes)
- **Secondary**: Pharmaceutical/biotech companies (drug development)
- **Tertiary**: Clinical oncologists (treatment planning)

#### **Market Size**
- Global cancer research market: **$25B+ annually**
- Computational biology software: **$5B+ annually**
- Drug discovery simulation: **$3B+ annually**
- **TAM**: $33B | **SAM**: $5B | **SOM** (Year 3): $10M

#### **Revenue Model**
1. **Open-Source Core** (Free)
   - Academic/research use
   - Community building
   - Citation/reputation

2. **Commercial Licensing** ($50K-500K/year)
   - Pharma/biotech companies
   - Drug development use
   - Custom features

3. **Consulting Services** ($200-400/hour)
   - Custom model development
   - Validation studies
   - Training/workshops

4. **SaaS Platform** ($500-5K/month)
   - Cloud-hosted simulations
   - Pay-per-compute
   - Managed service

5. **Grants** (Non-dilutive)
   - NIH, NSF, DoD funding
   - $500K-2M/year target

### Platform 2: eyentell (Professional Services SaaS)

#### **Target Market**
- **Primary**: Solo practitioners & small firms (1-10 people)
  - Lawyers (family law, estate planning, immigration)
  - Therapists/counselors (LMFT, LCSW, psychologists)
  - Mental health professionals
- **Secondary**: Small clinics and practices (10-50 people)

#### **Market Size**
- US solo/small law firms: **400,000+ practices**
- US mental health professionals: **200,000+ practitioners**
- Average spend on practice management: **$200-500/month**
- **TAM**: $3.6B | **SAM**: $500M | **SOM** (Year 3): $5M

#### **Revenue Model**
1. **Subscription Tiers**
   - **Solo**: $49/month (1 user, basic features)
   - **Small Practice**: $149/month (up to 5 users)
   - **Professional**: $299/month (up to 10 users, advanced AI)
   - **Enterprise**: Custom pricing (10+ users, white-label)

2. **Add-Ons**
   - AI triage: +$29/month
   - SMS/voice credits: Pay-as-you-go
   - Custom intake forms: +$19/month
   - Advanced analytics: +$49/month

3. **Implementation Services**
   - Onboarding: $500-2,000 one-time
   - Data migration: $1,000-5,000
   - Custom workflows: $2,000-10,000

---

## 2. Startup Phase Strategy (Months 0-12)

### Month 0-3: Foundation & Funding

#### **cognisom**
- âœ… **Week 1-2**: Apply for free compute
  - NVIDIA Inception (GPU credits)
  - AWS, Google, Azure research credits
  - Target: $50K-150K in credits

- âœ… **Week 3-4**: Repository setup
  - Make GitHub public
  - Documentation (README, ARCHITECTURE)
  - Demo videos

- **Month 2-3**: Prototype development
  - Single-cell model (Python)
  - GPU SSA kernel (CUDA)
  - Basic validation
  - Unit tests

#### **eyentell**
- **Month 1**: Market research
  - Interview 20-30 potential customers
  - Validate pain points
  - Refine feature set
  - Pricing validation

- **Month 2-3**: MVP specification
  - Core features only
  - Technical architecture
  - Privacy/compliance requirements
  - UI/UX wireframes

#### **Infrastructure**
- Set up company entity (LLC or C-corp)
- Business bank account
- Accounting system (QuickBooks)
- Legal consultation (formation, IP)
- **Budget**: $5K-10K

### Month 3-6: Development & Validation

#### **cognisom**
- **Month 3-4**: Core development
  - Immune system agents
  - Spatial diffusion
  - Prostate cancer model (basic)
  - Performance benchmarks

- **Month 5-6**: Grant applications
  - NIH NCI ITCR ($100K-400K)
  - NSF CSSI ($80K-300K)
  - Contact program officers
  - Submit applications

- **Milestone**: Working prototype + 2 grant applications submitted

#### **eyentell**
- **Month 3-5**: MVP development
  - Client onboarding flow
  - Intake form builder
  - Basic AI triage
  - Secure messaging (SMS/email)
  - Dashboard

- **Month 6**: Beta testing
  - 5-10 beta customers
  - Gather feedback
  - Iterate on UX
  - Fix bugs

- **Milestone**: MVP deployed + 5 paying beta customers

### Month 6-9: Early Traction

#### **cognisom**
- **Month 6-7**: Validation studies
  - Literature comparison
  - Benchmark against experimental data
  - Performance optimization
  - Documentation

- **Month 8-9**: Community building
  - Conference presentations (GTC, AACR)
  - Preprint publication (bioRxiv)
  - Open-source release (v0.1)
  - Early adopter outreach

- **Milestone**: 10-20 early users + 1 publication

#### **eyentell**
- **Month 6-8**: Customer acquisition
  - Launch marketing (content, SEO)
  - Direct outreach (LinkedIn, associations)
  - Referral program
  - Case studies from beta

- **Month 8-9**: Product iteration
  - Add most-requested features
  - Improve onboarding
  - Build integrations (calendars, payment)
  - Enhance AI capabilities

- **Milestone**: 20-50 paying customers ($2K-10K MRR)

### Month 9-12: Scale & Revenue

#### **cognisom**
- **Month 9-10**: Grant outcomes
  - Respond to reviews
  - Resubmit if needed
  - Secure $100K-500K funding
  - Hire first team member

- **Month 11-12**: Commercial development
  - Enterprise features
  - Commercial licensing terms
  - First pharma partnership discussions
  - SaaS platform architecture

- **Milestone**: $100K-500K in grants secured

#### **eyentell**
- **Month 9-11**: Growth acceleration
  - Paid advertising (Google, LinkedIn)
  - Partnership with professional associations
  - Webinars and demos
  - Content marketing

- **Month 12**: Revenue milestone
  - 50-100 paying customers
  - $10K-20K MRR
  - 90%+ retention rate
  - Product-market fit validated

- **Milestone**: $10K-20K MRR + product-market fit

---

## 3. Financial Projections (Year 1)

### Revenue Projections

#### **cognisom** (Year 1)
| Source | Q1 | Q2 | Q3 | Q4 | Year Total |
|--------|----|----|----|----|------------|
| Grants | $0 | $0 | $50K | $100K | $150K |
| Cloud Credits | $25K | $25K | $25K | $25K | $100K |
| Consulting | $0 | $0 | $5K | $10K | $15K |
| **Total** | **$25K** | **$25K** | **$80K** | **$135K** | **$265K** |

*Note: Grants and credits are non-dilutive funding, not traditional revenue*

#### **eyentell** (Year 1)
| Metric | Q1 | Q2 | Q3 | Q4 | Year Total |
|--------|----|----|----|----|------------|
| Customers | 0 | 5 | 25 | 75 | 75 |
| Avg. Revenue/Customer | $0 | $99 | $129 | $149 | $138 |
| MRR | $0 | $495 | $3,225 | $11,175 | $11,175 |
| **Quarterly Revenue** | **$0** | **$1,485** | **$9,675** | **$33,525** | **$44,685** |

#### **Combined Year 1 Total**: $309,685

### Expense Projections (Year 1)

| Category | Q1 | Q2 | Q3 | Q4 | Year Total |
|----------|----|----|----|----|------------|
| **Personnel** |
| Founder (deferred) | $0 | $0 | $0 | $0 | $0 |
| Contractor (dev) | $10K | $15K | $20K | $25K | $70K |
| Contractor (bio) | $0 | $5K | $10K | $15K | $30K |
| **Infrastructure** |
| Compute (after credits) | $2K | $3K | $5K | $8K | $18K |
| Software/tools | $1K | $1K | $1K | $1K | $4K |
| Hosting (eyentell) | $500 | $1K | $2K | $3K | $6.5K |
| **Operations** |
| Legal/accounting | $5K | $2K | $2K | $2K | $11K |
| Marketing | $1K | $3K | $5K | $10K | $19K |
| Travel/conferences | $0 | $2K | $3K | $3K | $8K |
| **Total Expenses** | **$19.5K** | **$32K** | **$48K** | **$67K** | **$166.5K** |

### Cash Flow Summary (Year 1)

| Quarter | Revenue | Expenses | Net Cash Flow | Cumulative |
|---------|---------|----------|---------------|------------|
| Q1 | $25K | $19.5K | +$5.5K | +$5.5K |
| Q2 | $26.5K | $32K | -$5.5K | $0 |
| Q3 | $89.7K | $48K | +$41.7K | +$41.7K |
| Q4 | $168.5K | $67K | +$101.5K | +$143.2K |
| **Year 1** | **$309.7K** | **$166.5K** | **+$143.2K** | **+$143.2K** |

**Key Insight**: Positive cash flow by end of Year 1 through combination of grants and SaaS revenue.

---

## 4. Funding Strategy

### Bootstrap + Non-Dilutive Funding (Preferred)

#### **Immediate (Month 0-3)**
- **Personal investment**: $10K-20K
  - Company formation
  - Initial development
  - Living expenses (if needed)

- **Free compute credits**: $50K-150K
  - NVIDIA Inception
  - AWS, Google, Azure
  - NIH STRIDES (if available)

#### **Near-term (Month 3-9)**
- **Grants**: $100K-500K
  - NIH NCI ITCR
  - NSF CSSI
  - DoD PCRP
  - Non-dilutive, no equity given up

- **eyentell revenue**: $5K-20K MRR
  - Customer subscriptions
  - Implementation fees
  - Funds operations

#### **Medium-term (Month 9-12)**
- **Additional grants**: $200K-1M
  - NIH R21
  - Cancer Grand Challenges (if qualified)
  - SBIR Phase I (requires for-profit entity)

- **eyentell growth**: $10K-30K MRR
  - Reinvest in product
  - Hire team members
  - Marketing spend

### Alternative: Venture Capital (If Needed)

**Only pursue if**:
- Grants rejected or delayed
- Need to scale eyentell faster
- Competitive pressure requires speed

**Potential raise**: $500K-1M seed round
- **Valuation**: $3M-5M pre-money
- **Dilution**: 15-25%
- **Use of funds**: Team hiring, product development, marketing

**Preferred investors**:
- Healthcare/biotech focused VCs
- Deep tech investors
- Strategic corporate investors (pharma, healthcare IT)

---

## 5. Team & Hiring

### Current Team (Month 0)
- **David Walker** â€” Founder & CEO
  - Technical architecture
  - Product development
  - Grant writing
  - Customer development

### Contractors (Month 1-6)
- **Full-stack developer** (Part-time, $50-75/hour)
  - eyentell MVP development
  - 20-30 hours/week
  - **Cost**: $4K-9K/month

- **Computational biologist** (Part-time, $75-100/hour)
  - cognisom model validation
  - 10-20 hours/week (starting Month 3)
  - **Cost**: $3K-8K/month

### First Hires (Month 6-12, if funded)
- **Senior Software Engineer** (Full-time)
  - CUDA/GPU programming
  - Backend architecture
  - **Salary**: $120K-150K + equity (0.5-1%)
  - **Hire**: Month 6-9

- **Computational Biologist** (Full-time)
  - Pathway modeling
  - Validation studies
  - Publications
  - **Salary**: $90K-120K + equity (0.5-1%)
  - **Hire**: Month 9-12

### Advisors (Month 3-12)
- **Cancer biologist** (Academic)
- **Clinical oncologist** (Validation partner)
- **GPU computing expert** (NVIDIA or academic)
- **Healthcare SaaS expert** (eyentell strategy)
- **Legal/compliance expert** (HIPAA, privacy)

**Compensation**: 0.1-0.25% equity each, vesting over 2-4 years

---

## 6. Key Milestones & Metrics

### cognisom Success Metrics

#### **Technical Milestones**
- âœ… Month 3: Single-cell model validated
- âœ… Month 6: GPU acceleration >10Ã— speedup
- âœ… Month 9: Immune surveillance model working
- âœ… Month 12: 10,000+ cell simulations

#### **Business Milestones**
- âœ… Month 2: $50K+ compute credits secured
- âœ… Month 6: 2 grant applications submitted
- âœ… Month 9: Open-source release (v0.1)
- âœ… Month 12: $100K-500K grants awarded

#### **Community Metrics**
- 10-20 early adopter users
- 100+ GitHub stars
- 1-2 publications/preprints
- 2-3 conference presentations

### eyentell Success Metrics

#### **Product Milestones**
- âœ… Month 3: MVP specification complete
- âœ… Month 6: Beta launch (5-10 customers)
- âœ… Month 9: Product-market fit validated
- âœ… Month 12: 50-100 paying customers

#### **Revenue Milestones**
- Month 6: First paying customer
- Month 9: $5K MRR
- Month 12: $10K-20K MRR
- Month 12: 90%+ retention rate

#### **Customer Metrics**
- CAC (Customer Acquisition Cost): <$500
- LTV (Lifetime Value): >$3,000
- LTV:CAC ratio: >6:1
- Churn rate: <5% monthly

---

## 7. Go-to-Market Strategy

### cognisom (Research Platform)

#### **Phase 1: Academic Adoption** (Month 0-6)
- **Strategy**: Open-source, community-driven
- **Tactics**:
  - GitHub repository with excellent docs
  - Tutorial videos and Colab notebooks
  - Conference presentations (GTC, AACR)
  - Preprint publications (bioRxiv)
  - Direct outreach to cancer labs

- **Goal**: 10-20 academic users, establish credibility

#### **Phase 2: Validation & Publications** (Month 6-12)
- **Strategy**: Scientific validation, peer review
- **Tactics**:
  - Collaborate with experimental labs
  - Publish validation studies
  - Benchmark against literature
  - Case studies and success stories

- **Goal**: 1-2 peer-reviewed publications, 50+ users

#### **Phase 3: Commercial Interest** (Month 12+)
- **Strategy**: Pharma/biotech partnerships
- **Tactics**:
  - Attend industry conferences (BIO, AACR)
  - Direct outreach to drug discovery teams
  - Pilot projects with biotech companies
  - Commercial licensing program

- **Goal**: 1-3 commercial pilots, $50K-200K revenue

### eyentell (SaaS Platform)

#### **Phase 1: Beta Launch** (Month 3-6)
- **Strategy**: Direct outreach, personal network
- **Tactics**:
  - LinkedIn outreach to target professionals
  - Professional association partnerships
  - Referrals from early adopters
  - Free beta period (3 months)

- **Goal**: 5-10 beta customers, product feedback

#### **Phase 2: Product-Market Fit** (Month 6-9)
- **Strategy**: Iterate based on feedback
- **Tactics**:
  - Weekly customer interviews
  - Rapid feature iteration
  - Improve onboarding flow
  - Build case studies

- **Goal**: 20-50 customers, 90%+ retention, clear value prop

#### **Phase 3: Growth** (Month 9-12)
- **Strategy**: Scalable acquisition channels
- **Tactics**:
  - Content marketing (SEO, blog)
  - Paid advertising (Google, LinkedIn)
  - Webinars and demos
  - Referral program
  - Partnership with associations

- **Goal**: 50-100 customers, $10K-20K MRR

---

## 8. Risk Analysis & Mitigation

### Technical Risks

#### **Risk 1: GPU performance doesn't scale**
- **Probability**: Low
- **Impact**: High
- **Mitigation**:
  - Prototype early (Month 1-3)
  - Benchmark against literature
  - Consult GPU experts
  - Have CPU fallback

#### **Risk 2: Biological model validation fails**
- **Probability**: Medium
- **Impact**: High
- **Mitigation**:
  - Use well-established pathways
  - Collaborate with experimental labs
  - Iterative validation approach
  - Focus on qualitative first, quantitative later

#### **Risk 3: eyentell technical complexity**
- **Probability**: Low
- **Impact**: Medium
- **Mitigation**:
  - Use proven tech stack
  - Start with MVP features only
  - Hire experienced contractors
  - Leverage existing libraries/APIs

### Market Risks

#### **Risk 1: Grants not awarded**
- **Probability**: Medium (50% success rate typical)
- **Impact**: High
- **Mitigation**:
  - Apply to multiple programs (10+)
  - Get program officer feedback
  - Resubmit with improvements
  - Have eyentell revenue as backup

#### **Risk 2: eyentell market too small**
- **Probability**: Low
- **Impact**: High
- **Mitigation**:
  - Validate with customer interviews
  - Start with niche (mental health)
  - Expand to adjacent markets
  - Pivot if needed

#### **Risk 3: Competitors enter market**
- **Probability**: Medium
- **Impact**: Medium
- **Mitigation**:
  - Move fast, establish brand
  - Build strong customer relationships
  - Focus on unique value (AI + privacy)
  - Open-source moat for cognisom

### Operational Risks

#### **Risk 1: Founder burnout**
- **Probability**: Medium
- **Impact**: High
- **Mitigation**:
  - Hire contractors early
  - Set realistic timelines
  - Maintain work-life balance
  - Build advisor network for support

#### **Risk 2: Cash flow problems**
- **Probability**: Low (with projections)
- **Impact**: High
- **Mitigation**:
  - Conservative financial planning
  - 6-month runway minimum
  - Multiple revenue streams
  - Line of credit if needed

#### **Risk 3: Regulatory/compliance issues**
- **Probability**: Low
- **Impact**: High
- **Mitigation**:
  - HIPAA compliance from day 1
  - Legal review of terms/privacy
  - Security audits
  - Insurance (E&O, cyber)

---

## 9. Success Criteria (End of Year 1)

### Minimum Viable Success
- âœ… cognisom: Working prototype + $100K grants secured
- âœ… eyentell: 30+ customers, $5K MRR
- âœ… Cash flow: Positive or break-even
- âœ… Team: 1-2 contractors or hires
- âœ… Validation: 1 publication + customer testimonials

### Target Success
- âœ… cognisom: $200K-500K grants + 50+ users + 2 publications
- âœ… eyentell: 75+ customers, $10K-15K MRR
- âœ… Cash flow: +$100K+ cumulative
- âœ… Team: 2 full-time hires + advisors
- âœ… Traction: Clear path to Series A or profitability

### Exceptional Success
- âœ… cognisom: $500K+ grants + commercial pilot + Nature/Science pub
- âœ… eyentell: 100+ customers, $20K+ MRR
- âœ… Cash flow: +$200K+ cumulative
- âœ… Team: 3-4 full-time + strong advisors
- âœ… Options: VC interest or path to $1M ARR

---

## 10. Next Steps (Week 1)

### Immediate Actions

#### **Day 1-2: Company Formation**
- [ ] Choose entity type (LLC vs C-corp)
- [ ] File formation documents
- [ ] Get EIN from IRS
- [ ] Open business bank account

#### **Day 3-4: Funding Applications**
- [ ] NVIDIA Inception application (30 min)
- [ ] AWS Cloud Credits application (30 min)
- [ ] Google Cloud Credits application (30 min)
- [ ] Azure Research Credits application (30 min)

#### **Day 5-7: Technical Setup**
- [ ] GitHub repository setup (cognisom)
- [ ] Documentation (README, ARCHITECTURE)
- [ ] Development environment
- [ ] Project management (Linear, GitHub Projects)

### Week 2-4 Actions

#### **cognisom**
- [ ] Single-cell model prototype (Python)
- [ ] Basic GPU kernel (CUDA)
- [ ] Unit tests
- [ ] Demo video (2-3 min)

#### **eyentell**
- [ ] Customer interviews (10-20 people)
- [ ] Feature prioritization
- [ ] Technical architecture doc
- [ ] UI/UX wireframes

#### **Business**
- [ ] Accounting setup (QuickBooks)
- [ ] Legal consultation (contracts, IP)
- [ ] Website/landing pages
- [ ] Social media presence

---

## 11. Multi-Stage Simulation Roadmap (Digital Human Trajectory)

Although this document focuses on **Year 0-1**, cognisom is explicitly designed to grow into a **full human digital cognisom** over the next 5-10 years. The startup phase establishes the *first rung* of a multi-stage simulation ladder:

1. **Single Cell Archetypes**  
   - **Scope (Year 0-1)**: Build and validate a high-fidelity mechanistic model for 1-2 *foundational cell types* involved in prostate biology and immunity:  
     - Prostate luminal epithelial cell  
     - Stromal fibroblast (support/ECM)  
     - CD8 T cell and NK cell (immune surveillance)  
   - **Functionality**:  
     - DNAâ†’RNAâ†’protein, metabolism, cell cycle  
     - Receptor signaling, cytokine responses  
     - Basic epigenetic state variables (methylation/acetylation indices)  
   - **Deliverables (Year 1)**:  
     - Validated single-cell models on GPU (10-100Ã— speedup vs CPU)  
     - Open-source reference implementations + tests  
   - **Cost (Year 1 portion)**: **$150K-300K** (grants + credits + founder time)

2. **Cell-Type Library for Prostate & Tumor Microenvironment**  
   - **Scope (late Year 1 â†’ Year 2)**: Expand to a **minimal basis set of cell types** required to reconstruct realistic prostate tissue and tumor microenvironments:  
     - Luminal, basal, neuroendocrine epithelial cells  
     - Stromal fibroblasts, smooth muscle cells  
     - Endothelial cells (vasculature), pericytes  
     - Immune cells (T cells, NK, macrophages, dendritic)  
   - **Strategy**:  
     - Reuse the same **GPU kernels and codebase**; parameterize cell types via configuration, not forks  
     - Establish a **common cell interface** so all types plug into the same engine  
   - **Goal**: Enough diversity to **assemble a digital prostate region** (normal + cancer + immune) as the first organ-level testbed.  
   - **Timing**: Begins in **Q3-Q4 of Year 1**, continues into Year 2 (see 3-5 Year Plan).  
   - **Incremental Cost (late Year 1)**: Included in Year 1 budget (contract comp bio + GPU time).

3. **Systematic Human Cell Atlas on Silicon**  
   - **Long-Term Vision**: Over 5-10 years, build a **library of mechanistic cell models** covering:  
     - Major parenchymal cells for each organ (hepatocytes, cardiomyocytes, neurons, etc.)  
     - Key stromal, immune, endothelial, and stem cell types  
     - Representative microbiome cell types and communities  
   - **Design Principle**: Each new cell type is a **parameterization** and extension of the same underlying engine, so all models are compatible and can be co-simulated.  
   - **Outcome**: A reusable **"cell codebase"** capable of expressing the diversity of the human body.

4. **From Cells to Tissue Patches (Prostate First)**  
   - **First Milestone (Years 1-2)**:  
     - Assemble 10K-100K cell simulations representing prostate tissue regions with:  
       - Normal glandular tissue  
       - In situ lesions  
       - Invasive cancer  
       - Immune infiltration and exclusion  
       - Local vasculature and lymphatics  
   - **Research Capabilities**:  
     - Test mutations (PTEN, TP53, AR)  
     - Immune evasion strategies  
     - Hormone manipulation (ADT) and drugs  
     - Spatial heterogeneity and microenvironmental niches  
   - **Feasibility**: Achievable with **2-8 modern NVIDIA GPUs** (A100/H100 class) and grants outlined in Year 1.

5. **Organ Blueprints & Reusable Profiles**  
   - **Concept**: For each organ, define a **blueprint**:  
     - Cell type mixture and spatial arrangement  
     - Typical gradients (oxygen, nutrients, hormones)  
     - Mechanical/structural constraints  
   - **Approach**:  
     - Start with prostate; then define blueprints for liver, lung, brain, bone marrow, etc.  
     - Save **"organ profiles"** (config + code) that can be re-instantiated on any compatible GPU cluster.  
   - **Hardware Strategy**: Reuse the **same physical GPUs**, swapping configurations rather than owning hardware per organ.  
   - **Timeline**: Organ blueprint work begins **late Year 1** in concept and moves into serious implementation in **Years 2-3**.

6. **Organ Systems â†’ Full-Body Digital Cognisom**  
   - **System-Level Integration (Years 3-5)**:  
     - Couple organ blueprints into **organ systems** (cardiovascular, immune, endocrine, nervous) using reduced-order and surrogate models.  
     - Maintain detailed simulations only where needed (e.g., tumor regions), with coarser models elsewhere.  
   - **Full Human Digital Cognisom (Years 5-10)**:  
     - Combine organ systems into a **coherent, interacting digital human** capable of:  
       - Supporting disease progression scenarios  
       - Testing mutations, viruses, drugs, and hormone regimes  
       - Modeling microbiome interactions, feedback loops, epigenetics, and immune education (thymus/T-cell training)  
   - **Hardware**:  
     - Early full-body prototypes feasible with **100-1,000 high-memory GPUs** plus aggressive use of ML surrogates and multi-resolution modeling (detailed in the 3-5 Year Plan).  

7. **Biological Richness & Communication (Design Requirements)**  
   - The roadmap explicitly includes:  
     - **Cell-cell communication**: paracrine, endocrine, juxtacrine, exosomes, nanotubes  
     - **Microbiome**: representative bacterial communities and host-microbe signaling  
     - **Epigenetics**: methylation, histone states, and their impact on gene expression dynamics  
     - **Immune education**: thymic selection, TCR repertoire formation, self vs non-self discrimination  
     - **Receptor logic**: how cellular receptors integrate signals to decide proliferation, apoptosis, migration, or differentiation  
   - These requirements drive the **initial single-cell design choices in Year 1**, so that future expansion does not require re-architecting the core engine.

### Year 0-1 Role in the 10-Year Vision

In practical business terms, **Year 0-1 is about building the first few rungs of a very tall ladder**:
- Prove that a single mechanistic cell model can run efficiently on GPUs.  
- Demonstrate that multiple distinct cell types (normal, cancer, immune) can share the same engine.  
- Show that a small prostate tissue patch (10K cells) can reproduce known biology and generate publishable insights.  
- Use that success to win **larger grants and partnerships** that fund the organ, organ-system, and full-body phases.

The detailed timelines, budgets, and hardware scaling for **organ systems** and a **full human digital cognisom** are laid out in the companion document: **[3-5 Year Business Plan](BUSINESS_PLAN_3_5_YEAR.md)**.

---

## Conclusion

The startup phase focuses on **validation and traction** for both platforms:

### **cognisom**: Prove technical feasibility + secure non-dilutive funding
- Open-source strategy builds community
- Grants provide runway without dilution
- Academic validation enables commercial opportunities

### **eyentell**: Achieve product-market fit + early revenue
- SaaS model provides predictable revenue
- Privacy-first positioning differentiates
- Professional services market is underserved

### **Combined Strategy**: De-risk through diversification
- Multiple revenue streams
- Non-dilutive funding (grants, credits)
- Complementary technologies
- Shared infrastructure reduces costs

**By end of Year 1**: Profitable or break-even, clear path to scale, strong technical and customer validation.

---

**Next Document**: [3-5 Year Business Plan](BUSINESS_PLAN_3_5_YEAR.md)
